EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Comparison of nonradioactive microtiter plate enzyme immunoassays for the sensitive detection of fentanyl



Comparison of nonradioactive microtiter plate enzyme immunoassays for the sensitive detection of fentanyl



Forensic Science International 113(1-3): 353-357, September 11th



Fentanyl is a very strong opioid with analgesic that are approximately 80 times stronger than those of morphine and therefore is used in major surgery and treatment of pain in tumor patients. Cases of fentanyl abuse by intravenous injection, inhalation, oral or nasal application have been reported especially in the USA. Therapeutic levels of fentanyl are as low as 1 ng/ml of serum and therefore a screening test must have a detection limit below that concentration. Recently three non-radioactive enzyme immunoassays (EIAs) have become commercially available from COZART, STC and DIAGNOSTIX, all of them supplied by MAHSAN Diagnostika for evaluation with serum samples from forensic and clinical cases. A calibration curve is obtained with samples that contain 0, 0.1, 0.5, 1 and 5 ng fentanyl per ml of negative serum. The calibration curve of COZART is especially in the low range, steeper than those of STC and DIAGNOSTIX. The cut-off for all these EIAs, however, can be set at 0.5 ng/ml. After the administration of therapeutic doses, fentanyl concentrations were between 3 and more than 5 ng/ml as determined with the EIAs. The presence of the typical drugs of abuse, e.g. heroin, methadone, cocaine, cannabinoids and amphetamines including the derivatives of methylenedioxyamphetamine, don't generate false-positive results. No cross-reactivity was also observed at toxic levels of benzodiazepines and paracetamol and therapeutic levels of barbiturates, phenothiazines, antidepressants and analgesics. The EIAs tested so far appear to be suitable for the detection of fentanyl at therapeutic levels. False-positive results or cross-reactivity towards other compounds have not been observed.

Accession: 010360256

Download citation: RISBibTeXText

PMID: 10978648

DOI: 10.1016/s0379-0738(00)00224-3

Download PDF Full Text: Comparison of nonradioactive microtiter plate enzyme immunoassays for the sensitive detection of fentanyl



Related references

Comparison of four microtiter plate enzyme immunoassays for milk progesterone determination in cows. Zuchthygiene (Berlin) 22(6): 247-252, 1987

The influence of heterology enzyme label and assay conditions on the sensitivity of microtiter plate enzyme immunoassays for progesterone in milk. Journal of Steroid Biochemistry 33(3): 433-438, 1989

Detection of rotavirus by hybridization with a nonradioactive synthetic DNA probe and comparison with commercial enzyme immunoassays and silver-stained polyacrylamide gels. Journal of Clinical Microbiology 27(6): 1277-1279, 1989

A highly sensitive enzyme-linked immunosorbent assay for human immunoglobulin E: comparison of microtiter plate and disk methodologies. Analytical Biochemistry 117(1): 53-60, 1981

A highly sensitive microtiter plate enzyme immunoassay for estradiol 17 beta. Journal of Immunological Methods 102(2): 165-172, 1987

Development of nonradioactive microtiter plate assays for nuclease activity. Analytical Biochemistry 309(1): 40-47, October 1, 2002

Multi-disease diagnostics A comparison of conventional microtiter plate-based ELISA to microsphere-based immunoassays. Abstracts of Papers American Chemical Society 224(1-2): ANYL 92, 2002

Rapid and sensitive detection of D-hydantoinase producing microorganisms by using microtiter plate assay. Biotechnology Techniques 10(11): 879-882, 1996

A chemiluminescent microtiter plate assay for sensitive detection of protein kinase activity. Analytical Biochemistry 244(2): 340-346, 1997

Nonradioactive fluorescence microtiter plate assay monitoring aptamer selections. Biotechniques 42(5): 578, 580, 582-578, 580, 582, 2007

Performance characteristics of a highly sensitive microtiter plate enzyme immunoassay for rapid testing of multiple drugs. Clinical Chemistry 50(6, Suppl S, Part 2): A130-A131, June, 2004

Rapid and sensitive detection of beta-galactosidase-producing yeasts by using microtiter plate assay. Biotechnology Techniques 11(6): 399-402, 1997

A new monoclonal antibody for the sensitive detection of atrazine with immunoassay in microtiter plate and dipstick format. Journal of Agricultural & Food Chemistry 41(6): 1006-1011, 1993

Detection of amplified Chlamydia trachomatis DNA using a microtiter plate-based enzyme immunoassay. European Journal of Clinical Microbiology & Infectious Diseases 13(9): 732-740, 1994